Proteomics

Dataset Information

0

Proteomic analysis of mPGES-2 on NAFLD


ABSTRACT: Proteomic analysis was performed using LC-MS/MS technology from Shanghai Aiao Biotechnology Co., Ltd.. The abundance of peptide fractions in the livers of Ptges2+/+ (WT) HFD and Ptges2-/- (KO) HFD groups was quantified using unlabeled quantitative methods and differentially expressed proteins in each group were tested for significance using t-test.

ORGANISM(S): Mus Musculus

SUBMITTER: Ying Sun  

PROVIDER: PXD035389 | iProX | Tue Jul 19 00:00:00 BST 2022

REPOSITORIES: iProX

altmetric image

Publications

Inhibition of mPGES-2 ameliorates NASH by activating NR1D1 via heme.

Zhong Dandan D   Cai Jie J   Hu Cheng C   Chen Jingshuo J   Zhang Rumeng R   Fan Chenyu C   Li Shanshan S   Zhang Hongxing H   Xu Zhou Z   Jia Zhanjun Z   Guo Dong D   Sun Ying Y  

Hepatology (Baltimore, Md.) 20220808 2


<h4>Background and aims</h4>Nonalcoholic fatty liver disease (NAFLD), a complex metabolic syndrome, has limited therapeutic options. Microsomal prostaglandin E synthase-2 (mPGES-2) was originally discovered as a prostaglandin E 2 (PGE 2 ) synthase; however, it does not produce PGE 2 in the liver. Moreover, the role of mPGES-2 in NAFLD remains undefined. Herein, we aimed to determine the function and mechanism of mPGES-2 in liver steatosis and steatohepatitis.<h4>Approach and results</h4>To evalu  ...[more]

Similar Datasets

2025-05-07 | PXD052372 | Pride
2025-02-21 | GSE290209 | GEO
2024-10-09 | GSE279130 | GEO
2015-03-01 | GSE64097 | GEO
2015-03-01 | E-GEOD-64097 | biostudies-arrayexpress
2021-02-17 | GSE160021 | GEO
2024-10-12 | GSE185735 | GEO
2021-02-17 | GSE160017 | GEO
2020-09-01 | GSE124959 | GEO
2025-05-28 | GSE294895 | GEO